Collectively, these many observations suggest that patients at risk of T1D, as judged by anti-GAD65/GAD67, might fail to develop T1D if they harbored powerfully neutralizing anti-IFNα antibodies. The gene discussed is IFNA2; the disease is type 1 diabetes mellitus.